Toll-like receptor 4 in COVID-19: friend or foe?

Future Virol. 2022 Mar:10.2217/fvl-2021-0249. doi: 10.2217/fvl-2021-0249. Epub 2022 Apr 19.

Abstract

Toll-like receptor 4, an innate immune sensor, is one of the key 'fate-deciding' regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic.

Keywords: COVID-19; SARS-CoV-2; TLR4; cytokine storm; immunotherapy.

Publication types

  • Editorial